相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。1102PRESULTS OF THE EXTENSION TRIAL OF OPTIM, A MULTICENTER, RANDOMIZED PHASE 3 TRIAL OF TALIMOGENE LAHERPAREPVEC (T-VEC) VS GM-CSF FOR UNRESECTED STAGE IIIB-IV MELANOMA
J.J. Nemunaitis et al.
ANNALS OF ONCOLOGY (2017)
Molecular Pathways: Mechanism of Action for Talimogene Laherparepvec, a New Oncolytic Virus Immunotherapy
Frederick J. Kohlhapp et al.
CLINICAL CANCER RESEARCH (2016)
Metastatic Melanoma - A Review of Current and Future Treatment Options
Emanual Maverakis et al.
ACTA DERMATO-VENEREOLOGICA (2015)
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
R. Dummer et al.
ANNALS OF ONCOLOGY (2015)
Talilmogene laherparepvec increases the anti-tumor efficacy of the anti PD-1 immune checkpoint blockade
Julia Piasecki et al.
CANCER RESEARCH (2015)
Oncolytic Virus Immunotherapy for Melanoma
Neal Dharmadhikari et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2015)
Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1-derived oncolytic immunotherapy
Kevin J. Harrington et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H. I. Andtbacka et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Society for Melanoma Research 2015 Congress
Pigment Cell & Melanoma Research (2015)
Innate and adaptive immunity contribute to the anti-tumor mechanisms of action of OncoVEXmGM-CSF
Keegan Cooke et al.
Journal for ImmunoTherapy of Cancer (2015)
Oncovex MGM-CSF –mediated regression of contralateral (non-injected) tumors in the A20 murine lymphoma model does not involve direct viral oncolysis
Keegan Cooke et al.
Journal for ImmunoTherapy of Cancer (2015)
Latest Advances in Chemotherapeutic, Targeted, and Immune Approaches in the Treatment of Metastatic Melanoma
Darshil J. Shah et al.
MAYO CLINIC PROCEEDINGS (2014)
The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
Howard L. Kaufman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Oncolytic Viruses in the Treatment of Cancer: A Review of Current Strategies
Md Zeyaullah et al.
PATHOLOGY & ONCOLOGY RESEARCH (2012)
Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
Howard L. Kaufman et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
Neil N. Senzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor
Jennifer C. C. Hu et al.
CLINICAL CANCER RESEARCH (2006)
ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties
BL Liu et al.
GENE THERAPY (2003)
分享论文
